The number of Americans who are infected with hepatitis C is falling, but that’s probably because more people who have been sickened by the virus are dying as a result, government researchers reported Monday.
04 March 2014 | Los Angeles Times
HIV positive people with hepatitis C coinfection who start combination antiretroviral therapy (ART) are less likely to develop decompensated liver disease, or liver failure, according to a study published in the March 1, 2014, edition of Clinical Infectious Diseases.
21 February 2014 | HIVandHepatitis.com
Hepatitis C patients who took low-dose aspirin after liver transplantation experienced slower fibrosis progression, researchers reported at the AASLD Liver Meeting this month in Washington, DC. Two other studies showed that cenicriviroc -- a drug being developed for HIV treatment that blocks both CCR5 and CCR2 cell surface receptors -- had anti-inflammatory and anti-fibrotic activity in mice and rats.
28 November 2013 | HIVandhepatitis.com
Dr Lawrence Mass, a co-founder of GMHC, calls for explicit US public health recommendations on hepatitis C testing for sexually active gay men.
31 October 2013 | Huffington Post (blog)
Lack of hepatitis C virus (HCV) genetic diversity in HCV/HIV-coinfected women independently raised the odds of liver disease in an analysis of the Women's Interagency HIV Study (WIHS). WIHS investigators believe absence of HCV diversity could prove a useful predictor of progression to liver disease.
12 October 2013 | NATAP
The Health Department today released the City’s first-ever plan for reducing illness and death from the hepatitis C virus (HCV), a disease that now accounts for more annual deaths nationwide than HIV/AIDS. In Hepatitis C in New York City: State of the Epidemic and Action Plan, the Health Department calls for new efforts to expand testing for HCV and to ensure that all people with HCV infection are evaluated for treatment.
08 October 2013 | New York City Department of Health and Mental Hygiene (press release)
A group of doctors says Canada should start screening all baby boomers for the potentially deadly liver disease hepatitis C.
01 October 2013 | The Globe and Mail
A risk score derived from four simple test results readily obtained during routine care may help identify the patients with chronic hepatitis C who are most at risk for developing hepatocellular carcinoma, according to a retrospective study published online July 12 in the European Journal of Internal Medicine.
01 August 2013 | Family Practice News
An influential health advisory group has reversed itself and concluded that all baby boomers should be tested for hepatitis C, meaning that under the new health law many insurance plans will have to provide screening without charge to patients. The group, the United States Preventive Services Task Force, announced its change of heart on Monday, saying there was likely to be some benefit from such screening.
25 June 2013 | New York Times
US Food and Drug Administration (FDA) today approved a test that identifies the genotype of hepatitis C virus (HCV) that a patient is carrying. The Abbott RealTime HCV Genotype II, which can differentiate genotypes 1, 1a, 1b, 2, 3, 4, and 5, using a sample of a patient’s blood plasma or serum, will aid healthcare professionals in determining the appropriate approach to treatment.
21 June 2013 | FDA.gov